Programme

THURSDAY, 7 SEPTEMBER 2017


Room: 1 | Dermatology in Practice
New Trends in Dermatology | Chair: J. Pfister
09:00-09:45 What's new in diagnostic procedures? What all can we use the microscope for?, P. Hensel (CH)
09:45-10:30 What’s new in diagnostic procedures? PCR in veterinary dermatology, P. Hensel (CH)

Room: 2 | Advances in Clinical Dermatology
Leishmaniosis | Chair: G. Zanna 
09:00-09:45 The diagnosis of leishmaniosis: from old to new knowledge, L. Solano Gallego (E)
09:45-10:30 Clinical staging, treatment and prognosis of canine leishmaniosis, L. Solano - Gallego (E)

Room: 3 | Cutting Edge Programme
Epidermal Apoptosis | Chair: F. Banovich 
09:00-09:45 Mechanism of Epidermal Cell Death, K. Linder (USA)
09:45-10:30 EM, SJS/TEN in humans part 1, M. Mockenhaupt (D)


10:30-11:15 Break


Room: 1 | Dermatology in Practice 
New Trends in Dermatology | Chair: C. Nett
11:15-12:00 What's new in diagnostic procedures? Allergy diagnosis, P. Hensel (CH)
12:00-12:45 What’s new in ectoparasite control?, E. Mendoza-Kuznekova (R)

Room: 2 | Advances in Clinical  Dermatology
Leishmaniosis | Chair: S. Colombo 
11:15-12:00 Strategies for the control of canine leishmaniosis, L. Ferrer (USA)
12:00-12:45 Journal Club 1, T. Nuttall (UK)

Room: 3 | Cutting Edge Programme
Epidermal Apoptosis  | Chair: F. Banovich 
11:15-12:00 EM, SJS/TEN in humans part 2, M. Mockenhaupt (D)
12:00-12:45 Erythema Multiforme, Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Dogs and Cats: Clinical and Pathological Features, K. Linder (USA)


12:45-15:00 Lunch
13:30-15:00 ECVD AGM


Room: 1 | Dermatology in Practice
New Trends in Dermatology | Chair: S. Paterson
15:00-15:45 What's new in anti-allergic therapy, T. Nuttall (UK)
15:45-16:30 What's new in antibacterial therapy, T. Nuttall (UK)

Room: 2 | Advances in Clinical Dermatology  
Drug Reactions | Chair: K. Timm
15:00-15:45 Drug reaction in humans, M. Mockenhaupt (D)
15:45-16:30 Epidermal drug reactions in dogs: selected topics, K. Linder (USA)

Room: 3 | OPEN COMMUNICATIONS
Free Communications | Chair: L. Panakova
15:00-15:15 Distinctive innate and adaptive immunological characteristics of dogs with different clinical stages of leishmaniosis, L. Ordeix
15:15-15:30 Are the hands of veterinary staff a reservoir for multidrug resistant bacteria? A randomized study to evaluate two hand hygiene rubs in a veterinary hospital, E. Espadalé  
15:30-15:45 Geographical differences in in vitro susceptibilities of Staphylococcus pseudintermedius to fusidic acid and chlorhexidine and the prevalence of associated resistance genes, S-M. Frosini 
15:45-16:00 Evaluation of the secretion of antimicrobial peptides in atopic and healthy dogs, D. Santoro
16:00-16:15 The role of VEGF-C in the development of feline squamous cell carcinomas, Y.B. Kabak
16:15-16:30 A randomized, blinded, controlled field study to assess the efficacy and safety of lotilaner tablets in controlling fleas in client-owned dogs in European countries, D.A. Cavalleri


16:30-17:15 Break


Room: 1 | Dermatology in Practice 
New Trends in Dermatology  | Chair: S. Paterson
17:15-18:00 What's new in otitis therapy, T. Nuttall (UK)

Room: 2 | Advances in Clinical Dermatology  
Drug Reactions | Chair: C. Noli
17:15-18:00 Cutaneous adverse events (AEs) in oncologic patients, L. Ferrer (USA)

Room: 3 | OPEN COMMUNICATIONS
Poster Presentations | Chair: E. Mendoza-Kuznekova
17:15-18:00 Poster Presentations
17:15-18:00 Quantitative polymerase chain reaction for Leishmania on stained cytologies: a new diagnostic method for the cutaneous lesions of leishmaniosis in dogs, T. Lima
17:15-18:00 Clinical follow-up of a series of dogs with papular dermatitis due to Leishmania infantum, L. Ordeix
17:15-18:00 Feline herpesvirus-1-associated dermatitis: viral load assessment by real time PCR for diagnostic purposes, M. Mazzei
17:15-18:00 Expression of adipokines in normal canine skin, T. Brément
17:15-18:00 Treatment of horses with insect-bite hypersensitivity with a spray of hydrocortisone aceponate: an open pilot study, K.E. Bergvall
17:15-18:00 The bioavailability of low-dose methotrexate after intravenous, subcutaneous and oral administration in beagle dogs, M. Jeannin


FRIDAY, 8 SEPTEMBER 2017


Room: 1 | Dermatology in Practice 
Feline Dermatology | Chair: D. Heripret
08:30-09:15 Dermatological emergencies in cats, S. White (USA)
09:15-10:00 Feline immune-mediated dermatosesE. Mendoza-Kuznekova (R)

Room: 2 | Advances in Clinical Dermatology 
Genetics | Chair: P. Roosje
08:30-09:15 Is this a genetic disease? Clues and key points for the clinician, L. Ferrer (USA)
09:15-10:00 Ichthyoses in animals, K. Linder (USA)

Room: 3 | Cutting Edge Programme 
Allergy | Chair: Th. Olivry
08:30-09:15 Lessons from studies on the epidemiology of atopic eczema, C. Flohr (UK)
09:15-10:00 New approaches to the prevention and treatment of human atopic eczema, C. Flohr (UK)


10:00-10:45 Break


Room: 1 | Dermatology in Practice 
Feline Dermatology | Chair: D. Heripret
10:45-11:30 The young, the old and the ugly: overview of pediatric and geriatric feline dermatology, S. Colombo (I)
11:30-12:15 Common or barely seen? Pyoderma in cats, E. Mendoza-Kuznekova (R)

Room: 2 | Advances in Clinical Dermatology 
Genetics | Chair: L. Ferrer
10:45-11:30 Hereditary epidermolysis bullosa in animals, T. Olivry (USA)
11:30-12:15 Genetic Defects of the Adnexa in Animals - Selected Topics: Hereditary Alopecias, K. Linder (USA)

Room: 3 | Cutting Edge Programme 
Allergy | Chair: R. Mueller
10:45-11:30 Immunomodulation of atopic dermatitis, T. Nuttall (UK)
11:30-12:15 Update on immunology - the immune response to parasites: Culicoides hypersentivitiy and new treatments, E. Marti (CH)


12:15-14:15 Lunch
13:00-14:15 ESVD AGM


Room: 1 | Dermatology in Practice 
Feline Dermatology | Chair: G. Zanna
14:15-15:00 Any news on an old problem? Feline allergy syndrome today, S. Colombo (I)

Room: 2 | Advances in Clinical Dermatology 
Genetics | Chair: M. Linek
14:15-15:00 Update on the genetics of complex animal skin diseases, T. Nuttall (UK)

Room: 3 | OPEN COMMUNICATIONS
Free Communications | Chair: R. Mueller
14:15-14:30 An allergen challenge results in a reversible reduction in stratum corneum filaggrin degradation products in sensitized atopic dogs, J. Olivry
14:30-14:45 Intrinsic alteration of the inflammatory pathways in canine atopic keratinocytes, D. Santoro
14:45-15:00 Total, Toxocara canis larval E/S antigen and allergen-specific IgE serum levels in atopic and healthy dogs, C. Favrot


15:00-15:45 Break


Room: 1 | Dermatology in Practice 
Feline Dermatology 
| Chair: G. Zanna
15:45-16:30 From stubborn to happy: feline food trials, S. Colombo (I)

Room: 2 | Advances in Clinical Dermatology  
What's your diagnosis? | Chair: J. Fontaine
15:45-16:30 What’s is your diagnosis? Challenging cases for the dermatologist, L. Ferrer (USA)

Room: 3 | OPEN COMMUNICATIONS
Free Communications | Chair: R. Mueller
15:45-16:00 Influence of a Toxocara canis infestation in a model of Dermatophagoides farinae-sensitized beagles, N. Fischer
16:00-16:15 Transcription infidelity causes a higher production of cationic peptides in Dermatophagoides farinae allergens compared to non allergenic mite proteins, B. Thouvenot
16:15-16:30 The role of macrophage migration inhibitory factor in canine atopic dermatitis, D.J. Gow

SATURDAY, 9 SEPTEMBER 2017


Room: 1 | Dermatology in Practice
Equine Dermatology | Chair: C. Nett
09:00-09:45 The pruritic (itchy) horse: how to approach and treat it, S. White (USA)
09:45-10:30 Update on bacterial and fungal skin infections, S. White (USA)

Room: 2 | Advanced Clinical Dermatology
Viral Diseases | Chair: L. Panakova
09:00-09:45 Update on feline viral diseases, C. Favrot (CH)
09:45-10:30 Update on equine papillomavirus diseases, C. Favrot (CH)

Room: 3 | Cutting Edge Programme
Leishmaniosis | Chair: A. Rostaher
09:00-09:45 Biology and epidemiology of canine leishmanias, L. Ferrer (USA)
09:45-10:30 Leishmaniasis in humans: from the bench to the field and back, N. Fasel (CH)


10:30-11:15 Break


Room: 1 | Dermatology in Practice
Equine Dermatology | Chair: S. Herbelet
11:15-12:00 Autoimmune skin diseases in equine patients, S. White (USA)
12:00-12:45 Photosensitization, pigmentation disorders & congenital skin diseases in horses, S. White (USA)

Room: 2 | Advances in Clinical Dermatology
Allergy | Chair: Th. Olivry
11:15-12:00 New options for allergen identification in allergic patients, C. Favrot (CH)
12:00-12:45 What's new in allergen-specific immunotherapy, C. Favrot (CH)

Room: 3 | Cutting Edge Programme
Leishmaniosis | Chair: C. Noli
11:15-12:00 Immune responses in canine leishmaniosis: natural disease and vaccination - part 1, L. Solano Gallego (E)
12:00-12:45 Immune responses in canine leishmaniosis: natural disease and vaccination - part 2, L. Solano Gallego (E)


12:45-14:15 Lunch


Room: 1 | Dermatology in Practice  
Topographic Dermatology | Chair: S. Herbelet
14:15-15:00 Dermatological diseases with oral involvement, P. Hensel (CH)
15:00-15:45 Diseases of the pinnae, E. Mendoza-Kuznekova (R)

Room 2: Advanced Clinical Dermatology 
Clinicopathological Conference | Chair: M. Linek
14:15-15:00 Clinicopathological Conference (pathologist), L. Ferrer (USA) and S. White (USA)
15:00-15:45 Clinicopatological Conference, M. Welle (CH) and C. Favrot (CH)

Room:3 | OPEN COMMUNICATIONS
Free Communications | Chair: E. Prélaz-Voegeli
14:15-14:30 Modulatory effects of oclacitinib on in vitro canine T-cell proliferation and cytokine production, F. Banovic
14:30-14:45 An open study on the efficacy of a commercial recombinant Der f 2 Dermatophagoides farinae  subcutaneous immunotherapy in dogs with atopic dermatitis, N. Fischer
14:45-15:00 A three-month, blinded, randomized clinical trial evaluating the efficacy and safety of lokivetmab compared to ciclosporin in client-owned dogs with atopic dermatitis, H. Moyaert
15:00-15:15 A clinical field trial evaluating the long-term efficacy and safety of lokivetmab in client-owned dogs with atopic dermatitis, H. Moyaert
15:15-15:30 The anti-inflammatory effect of topical tofacitinib on immediate and late-phase cutaneous allergic reactions in dogs: a placebo-controlled pilot study, F. Banovic
15:30-15:45 Efficacy of oclacitinib in allergic cats: a multicentric randomised, blinded, methylprednisolone-controlled study, C. Noli


15:45-16:30 Break


Room: 1 | Dermatology in Practice
Topographic Dermatology  | Chair: M. Linek
16:30-17:15 Diseases of the Paws and Claws, S. White (USA)
17:15-18:00 Diseases of the nose, S. Colombo (I)

Room: 2 | Advances in Clinical Dermatology 
Topic | Chair: L. Beco
16:30-17:15 Journal Club 2, C. Favrot (CH)
17:15-18:00 Dechra Awards

Room: 3 | OPEN COMMUNICATIONS
Free Communications | Chair: N. Fischer
16:30-16:45 DNA and protein analyses support the clinical reliability of Anallergenic, an extensively hydrolysed diet, I.D. Lesponne
16:45-17:00 Novel insights into the pathways regulating the canine hair cycle and their deregulation in alopecia, X, M. Brunner
17:00-17:15 Feline idiopathic head-and-neck dermatitis: an indicator of poor welfare responsive to major environmental modifications, N. Cochet Faivre

17:15-18:00 Poster presentation
17:15-18:00 IgE against cross-reactive carbohydrate determinants in client-owned dogs with atopic dermatitis, B.J. Levy
17:15-18:00 Cooking and processing reduce IgE sensitization to foods in dogs, C. Richard
17:15-18:00 Palmitoylethanolamide has anti-inflammatory and anti-oxidative effects in a cellular model of canine atopic dermatitis, H. Fuhrmann
17:15-18:00 Induction of anti-IgE autoantibodies with a synthetic vaccine with multiple antigenic peptides, K. Masuda
17:15-18:00 Histological and immunohistochemical changes associated with aging in canine skin, L. Ferrer
17:15-18:00 Can topical hydrocortisone aceponate effectively control allergic otitis externa and reduce the risk of recurrence? A double-blinded, placebo-controlled, prospective study, K.E. Bergvall
17:15-18:00 Testing for food-specific antibodies in the saliva and blood of atopic and normal dogs, L. Udraite Vovk 
17:15-18:00 Toxocara canis infestations influence seroconversions to Dermatophagoides farinae IgE, C. Favrot